Clinical Trial Update: Nighttime Valsartan in Hemodialysis Hypertension [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining nighttime valsartan for hypertension in patients undergoing hemodialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Nephropathy

Drugs mentioned

• VALSARTAN (Valsartan)

Snippet

Sponsor: Fifth Affiliated Hospital, Sun Yat-Sen University | Conditions: Hypertension;Nephropathy | Phase 4 | Status: UNKNOWN